Nature Communications (Aug 2023)
Diversity-oriented synthesis encoded by deoxyoligonucleotides
- Liam Hudson,
- Jeremy W. Mason,
- Matthias V. Westphal,
- Matthieu J. R. Richter,
- Jonathan R. Thielman,
- Bruce K. Hua,
- Christopher J. Gerry,
- Guoqin Xia,
- Heather L. Osswald,
- John M. Knapp,
- Zher Yin Tan,
- Praveen Kokkonda,
- Ben I. C. Tresco,
- Shuang Liu,
- Andrew G. Reidenbach,
- Katherine S. Lim,
- Jennifer Poirier,
- John Capece,
- Simone Bonazzi,
- Christian M. Gampe,
- Nichola J. Smith,
- James E. Bradner,
- Connor W. Coley,
- Paul A. Clemons,
- Bruno Melillo,
- C. Suk-Yee Hon,
- Johannes Ottl,
- Christoph E. Dumelin,
- Jonas V. Schaefer,
- Ann Marie E. Faust,
- Frédéric Berst,
- Stuart L. Schreiber,
- Frédéric J. Zécri,
- Karin Briner
Affiliations
- Liam Hudson
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Jeremy W. Mason
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Matthias V. Westphal
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Matthieu J. R. Richter
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Jonathan R. Thielman
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Bruce K. Hua
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Christopher J. Gerry
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Guoqin Xia
- Department of Chemistry, The Scripps Research Institute
- Heather L. Osswald
- Department of Chemistry, The Scripps Research Institute
- John M. Knapp
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Zher Yin Tan
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Praveen Kokkonda
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Ben I. C. Tresco
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Shuang Liu
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Andrew G. Reidenbach
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Katherine S. Lim
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Jennifer Poirier
- Novartis Institutes for BioMedical Research
- John Capece
- Novartis Institutes for BioMedical Research
- Simone Bonazzi
- Novartis Institutes for BioMedical Research
- Christian M. Gampe
- Novartis Institutes for BioMedical Research
- Nichola J. Smith
- Novartis Institutes for BioMedical Research
- James E. Bradner
- Novartis Institutes for BioMedical Research
- Connor W. Coley
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Paul A. Clemons
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Bruno Melillo
- Department of Chemistry, The Scripps Research Institute
- C. Suk-Yee Hon
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Johannes Ottl
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus
- Christoph E. Dumelin
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus
- Jonas V. Schaefer
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus
- Ann Marie E. Faust
- Novartis Institutes for BioMedical Research
- Frédéric Berst
- Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus
- Stuart L. Schreiber
- Chemical Biology and Therapeutics Science Program, Broad Institute
- Frédéric J. Zécri
- Novartis Institutes for BioMedical Research
- Karin Briner
- Novartis Institutes for BioMedical Research
- DOI
- https://doi.org/10.1038/s41467-023-40575-5
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 15
Abstract
Abstract Diversity-oriented synthesis (DOS) is a powerful strategy to prepare molecules with underrepresented features in commercial screening collections, resulting in the elucidation of novel biological mechanisms. In parallel to the development of DOS, DNA-encoded libraries (DELs) have emerged as an effective, efficient screening strategy to identify protein binders. Despite recent advancements in this field, most DEL syntheses are limited by the presence of sensitive DNA-based constructs. Here, we describe the design, synthesis, and validation experiments performed for a 3.7 million-member DEL, generated using diverse skeleton architectures with varying exit vectors and derived from DOS, to achieve structural diversity beyond what is possible by varying appendages alone. We also show screening results for three diverse protein targets. We will make this DEL available to the academic scientific community to increase access to novel structural features and accelerate early-phase drug discovery.